Scientific Music Medicine

Your Shopping Cart  Shopping Cart

Home   Site Map    Research    Reports    Intern. Experts    Music Preparations    Fundamentals    Store    Contact
peter hübner • micro music laboratories
M E D I C A L   R E S O N A N C E   T H E R A P Y   M U S I C®
R E D U C T I O N   O F   P S Y C H O – P H Y S I O L O G I C A L   M A N I F E S T A T I O N S   O F   S T R E S S

SCIENTIFIC RESEARCH

Research Fields Summary

Health of the Nervous System

Relaxation

Memory

Concentration

Headaches

Migraine

Multiple Sclerosis

Epilepsy

Dizziness

Arterial Nerves of the Arteries

Mental & Sensory Abilities

Cardiovascular Health

Health of the Hormone System

Health of the Immune System

Health of the Regenerative System

Healthy Sleep

Healthy Blood

Faster Recovery

Less Medication

Vital Energy

Relaxation

Release of STRESS

Harmony

Women’s Health

Pregnancy

Birth

Gynecological Surgery

Other Gynecological Problems

Children’s Health

Health of the Elderly

Health of Ear, Nose & Throat

Reduction of Pain

Headaches

Migraine

Birth

Health of the Skin

Neurodermatitis

Psoriasis

Health of Mind & Senses

Surgery

Psychological Health

Release of STRESS

Relaxation

Reduction of Anxiety

Courage to Face Life

Reducing Negative Values

Strengthening Positive Values

Harmony

Creativity

Exposure to Radioactivity

Mother & Child

 

 






Scientific Studies and Clinical Observations – Summary
Women’s Health
Pregnancy
  • Calming of the child inside the mother’s body during labor.

  • Taking of fetal heart activity out of the danger zone to a very satisfactory condition.

  • Significant improvement in the hormone status in pregnant women with somatic disorders leading to a significant increase in the well-being of mother and child, compared to only minor improvement in the control group.

  • Improvement of the kariopicnotic index (KPI) in risk pregnancies: in the Medical Resonance Therapy Music® group the KPI first fell to 10-12%, after 6 days to 7-8%, after 9 days to 6-8%. In the control group it first fell to 14-17%, after 6 days to 11-13%, after 9 days to 9-10% – so significantly less. The fall in the KPI shows a significant improvement in the course of the pregnancy.

  • Significant reduction in the number of premature births – from 14% down to 6,2% – since the introduction of treatment with Medical Resonance Therapy Music® for pregnant women facing the risk of miscarriage.

  • Faster normalization of excessively high blood pressure (reduction of 15-20 mmHg) in pregnant women with mild gestosis (OPH syndrome) than in the medication group.

  • Dispersion of the clinical risk characteristics in pregnant women with a threat of miscarriage:
    after 2-3 days there were no longer any clinical risk characteristics in 60% of the women, in 100% after 5-7 days. In the control group: the clinical risk characteristics had disappeared in 70% after 7-10 days, in 30% there was no complete dispersion of the risk characteristics.

  • Improvement of the general mental state in women with a mild gestosis (OPH-syndrome): For 7-10 days 13 women listened to the Medical Resonance Therapy Music® in the morning and after lunch and had no other therapy during these days. In 10 of the 13 women (77%) the treatment with the music caused a clear improvement of the mental state.

  • Calming of the fetus during labor: Acceleration and deceleration of fetal heart beat reduced – the fetus was calmed.

  • Reducing sleep disorders in pregnant women with somatic disorders in the last month of pregnancy: Before starting with the treatment, the frequency of sleep disorders was 86%, after the conventional treatment and the additional application of the Medical Resonance Therapy Music® it was only 7%. In the control group: prior to treatment 50%, after treatment an increase to 80%.

  • Normalization of sleep in 61% of pregnant women, compared to 30% in the medication group.

  • Improvement in the hormone status in pregnant women with somatic disorders: increase in the placentalactogen content from 217.5 nmol/l to 274.9 nmol/l and of the estriol level from 80.0 mol/24 hours to 103.3 mol/24 hours, leading to an improvement in the well-being of the mother and child.

  • Improvement in the fetal heart activity in pregnant women with gestosis (OPH syndrome): 14% faster than in the control group: the cardiotocogram showed a normalization of the condition of the fetus in 86% of the studies. After only 6 treatments the number of accelerations and the variability had increased and treatment could be completed after 12 days. In the control group normalization first occurred after 9-10 days and the entire treatment required 14 days.

  • Faster breakdown of the protein content in the urine of pregnant women with gestosis (OPH syndrome).

  • Improvement of sleep in 77% of the pregnant women with a mild form of gestosis (OPH syndrome). Reducing the frequency of sleep disorders from 86% to 7%. In the control group an increase from 50% to 80%.

  • Improvement in the hormone status in risk pregnancies: reduction of the cortisol level by 36% (double compared to that in the control group) coupled with a simultaneous increase in the progesterone level by 100% (almost four times as much as in the control group). The lowering of the cortisol level minimizes the stress risk-factor threatening the pregnancy, whilst the doubling of the progesterone increases the well-being of mother and child.

  • Reducing the frequency of headache attacks in pregnant women from 73% to 20%. In the control group there was an increase from 60% to 70%.

  • Improvement of restless and melancholy emotional states in pregnant women under threat of miscarriage in the first trimester of pregnancy: Evaluating the MMPI a healing effect of the MRT-Music® could be documented in 14 out of 15 pregnant women. The improvement in the mood and the general state stood at 87% of the reports. At the end of the treatment with the MRT-Music® the mental state of 69,2% of the women was normal again; there was no incidence of a deterioration in the mental state. The results of the control group: in 40% a complete normalization, in 40% a further aggravation of the state.

  • Normalization of the immune status in 56% of pregnant women from a group under the threat of miscarriage. In the control group the immune status normalized in 46% of the pregnant women.

  • Reduction of mental manifestations of stress: reduction of the emotional stress in pregnant women with somatic disorders by 47%, compared to no reduction of stress in the control group.

  • Taking of fetal heart activity out of the danger zone up to a level of 9.2 on the Krebs’ scale, which indicates a very satisfactory fetal condition.

  • Faster normalization of high blood pressure in pregnant women than in a control group receiving hypotonic and sedative medicine.

  • Shorter stay in hospital:
    Faster recovery in pregnant women under threat of miscarriage in the first trimester of pregnancy – the women could leave the hospital successfully treated already after 9-11 days: by 35% quicker than the patients in the control group.

  • Faster recovery in high-risk pregnancies with gestosis (OPH syndrome): in this group treatment could be completed 14% faster than in the control group.

  • Faster recovery of pregnant women at risk with a mild form of gestosis (OPH-syndrome): Improvement in fetal heart activity: 20 - 30% faster than in the control group.
    The cardiotocogram showed a normalization of the condition of the fetus in 86% of the studies. This was also subjectively confirmed by the mothers-to-be who felt better and better. After only 6 treatments the number of accelerations and the variability of fetal heart beat had improved, documenting an improved function of the fetal-placental system. The treatment in the MRT-Music® group could be completed after 12 days, normalization in the control group first occurred after 9-10 days and the entire treatment required 14 days – that is, the recovery of the MRT-Music® group was 14% faster.

  • Improvement of sleep in 77% of the pregnant women with a mild form of gestosis (OPH syndrome). Reducing the frequency of sleep disorders from 86% to 7%. In the control group an increase from 50% to 80%.
 


  Pregnancy and Birth   For this indication please use the program:

PREGNANCY & BIRTH
 
  If you want to look at the studies in detail, please visit:
SCIENTIFIC STUDIES & CLINICAL OBSERVATIONS – COMPLETE STUDIES
With kind permission of AAR EDITION INTERNATIONAL
© 1998- SCIENTIFIC MUSIC MEDICINE | Contact

Subject to change in the interests of scientific advancement.